Evidence map›Paper›PMID 36720646›Full record

ArticleeNeuro2023

Absence of VGLUT3 Expression Leads to Impaired Fear Memory in Mice.

Camille de Almeida, Nida Chabbah, Camille Eyraud, Caroline Fasano, Véronique Bernard, Nicolas Pietrancosta, Véronique Fabre, Salah El Mestikawy, Stephanie Daumas

Open access · goldAbstract read
In one paragraph

Article in eNeuro, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Camille de AlmeidaSorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris 75005, France.
Nida ChabbahSorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris 75005, France.
Camille EyraudSorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris 75005, France.
Caroline FasanoDouglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal QC H4H 1R3, Quebec, Canada.
Véronique BernardSorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris 75005, France.ORCID 0000-0003-4748-5167
Nicolas PietrancostaSorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris 75005, France.
Véronique FabreSorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris 75005, France.
Salah El MestikawySorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris 75005, France.
Stephanie DaumasSorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris 75005, France stephanie.daumas@sorbonne-universite.fr.ORCID 0000-0001-7048-7617
Université Paris-Seine · FRDouglas Mental Health University Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fear is an emotional mechanism that helps to cope with potential hazards. However, when fear is generalized, it becomes maladaptive and represents a core symptom of posttraumatic stress disorder (PTSD). Converging lines of research show that dysfunction of glutamatergic neurotransmission is a cardinal feature of trauma and stress related disorders such as PTSD. However, the involvement of glutamatergic co-transmission in fear is less well understood. Glutamate is accumulated into synaptic vesicles by vesicular glutamate transporters (VGLUTs). The atypical subtype, VGLUT3, is responsible for the co-transmission of glutamate with acetylcholine, serotonin, or GABA. To understand the involvement of VGLUT3-dependent co-transmission in aversive memories, we used a Pavlovian fear conditioning paradigm in VGLUT3

Indexed as

FearSynaptic TransmissionAnimalsGlutamic AcidMemory DisordersMiceVesicular Glutamate Transport ProteinsGlutamic AcidVesicular Glutamate Transport Proteinsaversive memoriespattern separationspatial memoryvesicular glutamate transporter type 3

Identifiers

PMID36720646
PMCPMC9953049
OpenAlexW4318696251

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.